Rocket Pharmaceuticals In... (RCKT)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
10.88
0.45 (4.31%)
At close: Jan 15, 2025, 1:44 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
PE Ratio | -10.25 | -6.08 | -8.14 | -20.71 | -13.4 | -7.83 | -2.39 | -3.81 | -3.05 | -8.6 | -6.63 | -8.33 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 5.11 | 2.72 | 3.04 | 6.03 | 3.63 | 3.01 | 1.48 | 2.23 | 1.91 | -1.59 | -1.3 | -1.63 |
P/FCF Ratio | -11.91 | -7.14 | -10.71 | -29.29 | -12.69 | -10.56 | -2.7 | -4.32 | -11.64 | -8.41 | -7.82 | -7.28 |
P/OCF Ratio | -12.92 | -7.49 | -11.39 | -40.69 | -17.25 | -10.85 | -2.7 | -4.38 | -11.91 | -8.41 | -7.82 | -7.28 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.05 | 0.05 | 0.05 | 0.12 | 0.15 | 0.21 | 1.04 | 0.67 | 0.00 | -0.14 | -0.17 | -0.09 |
Quick Ratio | 7.80 | 9.29 | 17.69 | 14.94 | 16.81 | 13.60 | 24.83 | 17.80 | 27.13 | 0.98 | 4.00 | 0.38 |
Current Ratio | 7.80 | 9.29 | 17.69 | 14.94 | 16.81 | 13.60 | 24.83 | 17.80 | 27.13 | 0.98 | 4.00 | 0.38 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -138.48 | -117.52 | -28.4 | -17.8 | -15.92 | -13.58 | -7.47 | -29.53 | -16.58 | -7.86 | -7.53 | -27.46 |
Return on Equity (ROE) | -0.5 | -0.45 | -0.37 | -0.29 | -0.27 | -0.38 | -0.62 | -0.59 | -0.62 | 0.18 | 0.20 | 0.20 |
Return on Assets (ROA) | -0.43 | -0.4 | -0.34 | -0.25 | -0.22 | -0.3 | -0.29 | -0.33 | -0.6 | -1.73 | -0.59 | -4.26 |
Return on Capital (ROIC) | -0.5 | -0.44 | -0.35 | -0.24 | -0.22 | -0.3 | -0.27 | -0.34 | -0.19 | -4.24 | -0.69 | 2.50 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |